Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ephrin receptor activity	EPHB4 EPHA10 EPHA3 EPHA4	5.23e-08	19	40	4	GO:0005003
GeneOntologyMolecularFunction	transmembrane-ephrin receptor activity	EPHA10 EPHA3 EPHA4	3.33e-06	15	40	3	GO:0005005
GeneOntologyMolecularFunction	phorbol ester receptor activity	UNC13B UNC13C	3.91e-06	2	40	2	GO:0001565
GeneOntologyMolecularFunction	non-kinase phorbol ester receptor activity	UNC13B UNC13C	3.91e-06	2	40	2	GO:0001566
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	EPHB4 EPHA10 EPHA3 EPHA4	8.56e-06	65	40	4	GO:0004714
GeneOntologyMolecularFunction	protein tyrosine kinase activity	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	1.01e-05	145	40	5	GO:0004713
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	EPHB4 EPHA10 EPHA3 EPHA4	2.49e-05	85	40	4	GO:0019199
GeneOntologyMolecularFunction	monoatomic ion channel activity	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 KCNH4 GABRA4	3.13e-05	459	40	7	GO:0005216
GeneOntologyMolecularFunction	channel activity	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 KCNH4 GABRA4	7.33e-05	525	40	7	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 KCNH4 GABRA4	7.42e-05	526	40	7	GO:0022803
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	EPHB4 JAK1 PIP5K1B POLR1A PRKAG2 EPHA10 GYS1 EPHA3 EPHA4	7.86e-05	938	40	9	GO:0016772
GeneOntologyMolecularFunction	GPI-linked ephrin receptor activity	EPHA3 EPHA4	8.16e-05	7	40	2	GO:0005004
GeneOntologyMolecularFunction	inorganic molecular entity transmembrane transporter activity	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 SLC9C2 KCNH4 GABRA4	1.09e-04	758	40	8	GO:0015318
GeneOntologyMolecularFunction	monoatomic ion transmembrane transporter activity	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 SLC9C2 KCNH4 GABRA4	1.48e-04	793	40	8	GO:0015075
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	GABRG2 GRIN2D GABRA4	2.02e-04	57	40	3	GO:1904315
GeneOntologyMolecularFunction	benzodiazepine receptor activity	GABRG2 GABRA4	2.13e-04	11	40	2	GO:0008503
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	GABRG2 GRIN2D GABRA4	2.35e-04	60	40	3	GO:0099529
GeneOntologyMolecularFunction	transmitter-gated channel activity	GABRG2 GRIN2D GABRA4	2.98e-04	65	40	3	GO:0022835
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity	GABRG2 GRIN2D GABRA4	2.98e-04	65	40	3	GO:0022824
GeneOntologyMolecularFunction	postsynaptic neurotransmitter receptor activity	GABRG2 GRIN2D GABRA4	4.55e-04	75	40	3	GO:0098960
GeneOntologyMolecularFunction	diacylglycerol binding	UNC13B UNC13C	4.61e-04	16	40	2	GO:0019992
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	EPHB4 JAK1 PIP5K1B PRKAG2 EPHA10 EPHA3 EPHA4	4.63e-04	709	40	7	GO:0016773
GeneOntologyMolecularFunction	extracellular ligand-gated monoatomic ion channel activity	GABRG2 GRIN2D GABRA4	4.92e-04	77	40	3	GO:0005230
GeneOntologyMolecularFunction	gated channel activity	TMEM63B GABRG2 GRIN2D KCNH4 GABRA4	5.17e-04	334	40	5	GO:0022836
GeneOntologyMolecularFunction	monoatomic cation channel activity	TMEM63B ATP6V1A GRIN2D NOX5 KCNH4	5.83e-04	343	40	5	GO:0005261
GeneOntologyMolecularFunction	GABA-gated chloride ion channel activity	GABRG2 GABRA4	5.87e-04	18	40	2	GO:0022851
GeneOntologyMolecularFunction	ligand-gated monoatomic ion channel activity	TMEM63B GABRG2 GRIN2D GABRA4	5.89e-04	193	40	4	GO:0015276
GeneOntologyMolecularFunction	ligand-gated channel activity	TMEM63B GABRG2 GRIN2D GABRA4	6.36e-04	197	40	4	GO:0022834
GeneOntologyMolecularFunction	GABA-A receptor activity	GABRG2 GABRA4	6.55e-04	19	40	2	GO:0004890
GeneOntologyMolecularFunction	kinase activity	EPHB4 JAK1 PIP5K1B PRKAG2 EPHA10 EPHA3 EPHA4	7.23e-04	764	40	7	GO:0016301
GeneOntologyMolecularFunction	transporter activity	TMEM63B GRAMD1B GABRG2 ATP6V1A GRIN2D NOX5 SLC9C2 KCNH4 GABRA4	8.36e-04	1289	40	9	GO:0005215
GeneOntologyMolecularFunction	GABA receptor activity	GABRG2 GABRA4	8.81e-04	22	40	2	GO:0016917
GeneOntologyMolecularFunction	syntaxin-1 binding	UNC13B UNC13C	1.05e-03	24	40	2	GO:0017075
GeneOntologyMolecularFunction	neurotransmitter receptor activity	GABRG2 GRIN2D GABRA4	1.05e-03	100	40	3	GO:0030594
GeneOntologyMolecularFunction	protein kinase activity	EPHB4 JAK1 PRKAG2 EPHA10 EPHA3 EPHA4	1.15e-03	600	40	6	GO:0004672
GeneOntologyMolecularFunction	proton channel activity	ATP6V1A NOX5	1.33e-03	27	40	2	GO:0015252
GeneOntologyMolecularFunction	inorganic cation transmembrane transporter activity	TMEM63B ATP6V1A GRIN2D NOX5 SLC9C2 KCNH4	1.45e-03	627	40	6	GO:0022890
GeneOntologyMolecularFunction	monoatomic cation transmembrane transporter activity	TMEM63B ATP6V1A GRIN2D NOX5 SLC9C2 KCNH4	1.94e-03	664	40	6	GO:0008324
GeneOntologyMolecularFunction	transmembrane transporter activity	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 SLC9C2 KCNH4 GABRA4	2.05e-03	1180	40	8	GO:0022857
GeneOntologyMolecularFunction	glycosyltransferase activity	HAS1 FUT6 ST8SIA3 GYS1	2.57e-03	288	40	4	GO:0016757
GeneOntologyMolecularFunction	ligand-gated monoatomic anion channel activity	GABRG2 GABRA4	4.51e-03	50	40	2	GO:0099095
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	TMEM63B EPHB4 GABRG2 GRIN2D EPHA10 EPHA3 EPHA4 GABRA4	4.77e-03	1353	40	8	GO:0004888
GeneOntologyMolecularFunction	cysteine-type endopeptidase regulator activity involved in apoptotic process	CTSL NAIP	5.24e-03	54	40	2	GO:0043028
GeneOntologyMolecularFunction	proton transmembrane transporter activity	ATP6V1A NOX5 SLC9C2	6.28e-03	188	40	3	GO:0015078
GeneOntologyMolecularFunction	protein phosphatase binding	JAK1 PPP2R2A MYO16	8.51e-03	210	40	3	GO:0019903
GeneOntologyMolecularFunction	hexosyltransferase activity	HAS1 FUT6 GYS1	8.62e-03	211	40	3	GO:0016758
GeneOntologyBiologicalProcess	ephrin receptor signaling pathway	EPHB4 EPHA10 EPHA3 EPHA4	3.22e-06	54	39	4	GO:0048013
GeneOntologyBiologicalProcess	fasciculation of motor neuron axon	EPHA3 EPHA4	3.48e-06	2	39	2	GO:0097156
GeneOntologyBiologicalProcess	fasciculation of sensory neuron axon	EPHA3 EPHA4	1.04e-05	3	39	2	GO:0097155
GeneOntologyBiologicalProcess	dense core granule priming	UNC13B UNC13C	2.09e-05	4	39	2	GO:0061789
GeneOntologyBiologicalProcess	negative regulation of synaptic plasticity	UNC13B UNC13C	5.20e-05	6	39	2	GO:0031914
GeneOntologyBiologicalProcess	presynaptic dense core vesicle exocytosis	UNC13B UNC13C	1.55e-04	10	39	2	GO:0099525
GeneOntologyBiologicalProcess	carbohydrate metabolic process	HAS1 PRKAG2 FUT6 ST8SIA3 GLB1L GYS1 OTOG	1.84e-04	646	39	7	GO:0005975
GeneOntologyBiologicalProcess	monoatomic ion transmembrane transport	TMEM63B GABRG2 ATP6V1A GRIN2D NOX5 SLC9C2 PLCH2 KCNH4 GABRA4	1.86e-04	1115	39	9	GO:0034220
GeneOntologyBiologicalProcess	neuronal dense core vesicle exocytosis	UNC13B UNC13C	2.27e-04	12	39	2	GO:0099011
GeneOntologyBiologicalProcess	dense core granule exocytosis	UNC13B UNC13C	3.60e-04	15	39	2	GO:1990504
GeneOntologyBiologicalProcess	regulation of postsynaptic membrane potential	UNC13B GABRG2 GRIN2D GABRA4	3.63e-04	180	39	4	GO:0060078
GeneOntologyCellularComponent	protein phosphatase type 2A complex	PPP2R2A PPP2R2D	5.36e-04	18	40	2	GO:0000159
GeneOntologyCellularComponent	postsynaptic specialization membrane	GABRG2 GRIN2D EPHA4 GABRA4	5.78e-04	201	40	4	GO:0099634
GeneOntologyCellularComponent	GABA-A receptor complex	GABRG2 GABRA4	5.98e-04	19	40	2	GO:1902711
GeneOntologyCellularComponent	GABA receptor complex	GABRG2 GABRA4	7.33e-04	21	40	2	GO:1902710
GeneOntologyCellularComponent	synaptic membrane	UNC13B GABRG2 UNC13C GRIN2D EPHA4 GABRA4	7.85e-04	583	40	6	GO:0097060
GeneOntologyCellularComponent	presynaptic active zone cytoplasmic component	UNC13B UNC13C	8.81e-04	23	40	2	GO:0098831
GeneOntologyCellularComponent	neuromuscular junction	UNC13B UNC13C EPHA4	1.28e-03	112	40	3	GO:0031594
Domain	RECEPTOR_TYR_KIN_V_2	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	PS00790
Domain	Eph_TM	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	IPR027936
Domain	Tyr_kinase_rcpt_V_CS	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	IPR001426
Domain	EPH_lbd	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	SM00615
Domain	Ephrin_lbd	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	PF01404
Domain	EphA2_TM	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	PF14575
Domain	Tyr_kinase_ephrin_rcpt	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	IPR016257
Domain	Ephrin_rcpt_lig-bd_dom	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	IPR001090
Domain	EPH_LBD	EPHB4 EPHA10 EPHA3 EPHA4	1.78e-08	14	40	4	PS51550
Domain	Ephrin_rec_like	EPHB4 EPHA10 EPHA3 EPHA4	2.21e-07	25	40	4	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB4 EPHA10 EPHA3 EPHA4	2.21e-07	25	40	4	IPR011641
Domain	-	EPHB4 GLB1L EPHA10 EPHA3 EPHA4	4.69e-07	73	40	5	2.60.120.260
Domain	TyrKc	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	1.20e-06	88	40	5	SM00219
Domain	Tyr_kinase_cat_dom	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	1.20e-06	88	40	5	IPR020635
Domain	Galactose-bd-like	EPHB4 GLB1L EPHA10 EPHA3 EPHA4	1.66e-06	94	40	5	IPR008979
Domain	PROTEIN_KINASE_TYR	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	1.94e-06	97	40	5	PS00109
Domain	Tyr_kinase_AS	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	1.94e-06	97	40	5	IPR008266
Domain	Pkinase_Tyr	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	7.88e-06	129	40	5	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	1.09e-05	138	40	5	IPR001245
Domain	Unc-13	UNC13B UNC13C	1.34e-05	3	40	2	IPR027080
Domain	PP2A_PR55	PPP2R2A PPP2R2D	2.68e-05	4	40	2	IPR000009
Domain	PP2A_PR55_CS	PPP2R2A PPP2R2D	2.68e-05	4	40	2	IPR018067
Domain	PR55_2	PPP2R2A PPP2R2D	2.68e-05	4	40	2	PS01025
Domain	PR55_1	PPP2R2A PPP2R2D	2.68e-05	4	40	2	PS01024
Domain	SAM	EPHB4 EPHA10 EPHA3 EPHA4	3.69e-05	88	40	4	SM00454
Domain	Munc13_dom-2	UNC13B UNC13C	4.45e-05	5	40	2	IPR014772
Domain	Membr_traf_MHD	UNC13B UNC13C	4.45e-05	5	40	2	PF10540
Domain	MHD2	UNC13B UNC13C	4.45e-05	5	40	2	PS51259
Domain	Munc13_subgr_dom-2	UNC13B UNC13C	4.45e-05	5	40	2	IPR019558
Domain	DUF1041	UNC13B UNC13C	4.45e-05	5	40	2	SM01145
Domain	SAM_DOMAIN	EPHB4 EPHA10 EPHA3 EPHA4	4.99e-05	95	40	4	PS50105
Domain	SAM	EPHB4 EPHA10 EPHA3 EPHA4	5.41e-05	97	40	4	IPR001660
Domain	-	EPHB4 EPHA10 EPHA3 EPHA4	7.65e-05	106	40	4	1.10.150.50
Domain	DUF1041	UNC13B UNC13C	9.33e-05	7	40	2	PF06292
Domain	Munc13_1	UNC13B UNC13C	9.33e-05	7	40	2	IPR014770
Domain	CAPS_dom	UNC13B UNC13C	9.33e-05	7	40	2	IPR010439
Domain	MHD1	UNC13B UNC13C	9.33e-05	7	40	2	PS51258
Domain	SAM/pointed	EPHB4 EPHA10 EPHA3 EPHA4	1.12e-04	117	40	4	IPR013761
Domain	Ephrin_rec_like	EPHB4 EPHA3	2.43e-04	11	40	2	PF07699
Domain	fn3	EPHB4 EPHA10 EPHA3 EPHA4	3.91e-04	162	40	4	PF00041
Domain	FN3	EPHB4 EPHA10 EPHA3 EPHA4	6.45e-04	185	40	4	SM00060
Domain	FN3	EPHB4 EPHA10 EPHA3 EPHA4	8.46e-04	199	40	4	PS50853
Domain	FN3_dom	EPHB4 EPHA10 EPHA3 EPHA4	1.02e-03	209	40	4	IPR003961
Domain	GABAA/Glycine_rcpt	GABRG2 GABRA4	1.10e-03	23	40	2	IPR006028
Domain	CNMP_BINDING_1	SLC9C2 KCNH4	2.13e-03	32	40	2	PS00888
Domain	CNMP_BINDING_2	SLC9C2 KCNH4	2.13e-03	32	40	2	PS00889
Domain	cNMP	SLC9C2 KCNH4	2.40e-03	34	40	2	SM00100
Domain	cNMP_binding	SLC9C2 KCNH4	2.40e-03	34	40	2	PF00027
Domain	cNMP-bd_dom	SLC9C2 KCNH4	2.54e-03	35	40	2	IPR000595
Domain	CNMP_BINDING_3	SLC9C2 KCNH4	2.54e-03	35	40	2	PS50042
Domain	C2	UNC13B UNC13C PLCH2	2.76e-03	131	40	3	PF00168
Domain	PROTEIN_KINASE_ATP	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	2.84e-03	459	40	5	PS00107
Domain	cNMP-bd-like	SLC9C2 KCNH4	2.99e-03	38	40	2	IPR018490
Domain	C2	UNC13B UNC13C PLCH2	3.13e-03	137	40	3	SM00239
Domain	C2	UNC13B UNC13C PLCH2	3.46e-03	142	40	3	PS50004
Domain	Prot_kinase_dom	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	3.73e-03	489	40	5	IPR000719
Domain	SAM_2	EPHA3 EPHA4	3.82e-03	43	40	2	PF07647
Domain	PROTEIN_KINASE_DOM	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	3.86e-03	493	40	5	PS50011
Domain	-	UNC13B UNC13C PLCH2	3.89e-03	148	40	3	2.60.40.150
Domain	Neurotransmitter_ion_chnl_CS	GABRG2 GABRA4	4.18e-03	45	40	2	IPR018000
Domain	Neur_chan_memb	GABRG2 GABRA4	4.36e-03	46	40	2	PF02932
Domain	Neur_chan_LBD	GABRG2 GABRA4	4.55e-03	47	40	2	PF02931
Domain	NEUROTR_ION_CHANNEL	GABRG2 GABRA4	4.55e-03	47	40	2	PS00236
Domain	Neurotrans-gated_channel_TM	GABRG2 GABRA4	4.55e-03	47	40	2	IPR006029
Domain	-	GABRG2 GABRA4	4.55e-03	47	40	2	2.70.170.10
Domain	Neur_channel	GABRG2 GABRA4	4.55e-03	47	40	2	IPR006201
Domain	Neur_chan_lig-bd	GABRG2 GABRA4	4.55e-03	47	40	2	IPR006202
Domain	-	SLC9C2 KCNH4	4.74e-03	48	40	2	2.60.120.10
Domain	C2_dom	UNC13B UNC13C PLCH2	5.18e-03	164	40	3	IPR000008
Domain	RmlC-like_jellyroll	SLC9C2 KCNH4	5.34e-03	51	40	2	IPR014710
Domain	Kinase-like_dom	EPHB4 JAK1 EPHA10 EPHA3 EPHA4	5.75e-03	542	40	5	IPR011009
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB4 EPHA10 EPHA3 EPHA4	1.14e-05	51	39	4	M27311
Pathway	REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE	EPHA10 EPHA3 EPHA4	6.81e-05	29	39	3	M27309
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB4 EPHA10 EPHA4	1.10e-04	34	39	3	MM15025
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	EPHB4 EPHA10 EPHA3 EPHA4	1.17e-04	92	39	4	M27201
Pubmed	Identification of tyrosine kinases expressed in the male mouse gubernaculum during development.	EPHB4 JAK1 EPHA3 EPHA4	2.06e-08	25	41	4	15254900
Pubmed	Degenerate PCR-based cloning method for Eph receptors and analysis of their expression in the developing murine central nervous system and vasculature.	EPHB4 EPHA3 EPHA4	1.27e-07	9	41	3	11403717
Pubmed	Embryonic expression of EphA receptor genes in mice supports their candidacy for involvement in cleft lip and palate.	EPHA10 EPHA3 EPHA4	1.81e-07	10	41	3	25073978
Pubmed	EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes.	EPHA10 EPHA3 EPHA4	1.81e-07	10	41	3	16547242
Pubmed	Expression and requirement of T-box transcription factors Tbx2 and Tbx3 during secondary palate development in the mouse.	EPHB4 EPHA10 EPHA3 EPHA4	3.99e-07	51	41	4	19769959
Pubmed	Ephrin Ligands and Eph Receptors Show Regionally Restricted Expression in the Developing Palate and Tongue.	EPHB4 EPHA3 EPHA4	5.49e-07	14	41	3	26941654
Pubmed	Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm.	EPHB4 EPHA3 EPHA4	1.02e-06	17	41	3	12971893
Pubmed	Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice.	EPHB4 EPHA3 EPHA4	1.02e-06	17	41	3	12217323
Pubmed	Increased EphA/ephrinA expression in hippocampus of pilocarpine treated mouse.	EPHA10 EPHA4	1.36e-06	2	41	2	23352741
Pubmed	Munc13-independent vesicle priming at mouse photoreceptor ribbon synapses.	UNC13B UNC13C	1.36e-06	2	41	2	22674279
Pubmed	Two highly related regulatory subunits of PP2A exert opposite effects on TGF-beta/Activin/Nodal signalling.	PPP2R2A PPP2R2D	1.36e-06	2	41	2	18697906
Pubmed	Segregation of axial motor and sensory pathways via heterotypic trans-axonal signaling.	EPHA3 EPHA4	1.36e-06	2	41	2	18403711
Pubmed	Association between GABA(A) receptor subunit polymorphisms and autism spectrum disorder (ASD).	GABRG2 GABRA4	1.36e-06	2	41	2	26239769
Pubmed	Mutation in the γ2-subunit of AMP-activated protein kinase stimulates cardiomyocyte proliferation and hypertrophy independent of glycogen storage.	PRKAG2 GYS1	1.36e-06	2	41	2	24503893
Pubmed	Expression of Ephs and ephrins in developing mouse inner ear.	EPHB4 EPHA3 EPHA4	1.45e-06	19	41	3	12684176
Pubmed	Eph receptors and ephrins: effectors of morphogenesis.	EPHB4 EPHA3 EPHA4	1.71e-06	20	41	3	10207129
Pubmed	Multiple roles of EPH receptors and ephrins in neural development.	EPHB4 EPHA3 EPHA4	1.71e-06	20	41	3	11256076
Pubmed	The Eph family receptors and ligands.	EPHB4 EPHA3 EPHA4	1.71e-06	20	41	3	9576626
Pubmed	The ephrins and Eph receptors in neural development.	EPHB4 EPHA3 EPHA4	1.71e-06	20	41	3	9530499
Pubmed	Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee.	EPHB4 EPHA3 EPHA4	1.99e-06	21	41	3	9267020
Pubmed	Developmental expression of Eph and ephrin family genes in mammalian small intestine.	EPHB4 EPHA3 EPHA4	1.99e-06	21	41	3	20112066
Pubmed	Eph receptors and ephrins demarcate cerebellar lobules before and during their formation.	EPHB4 EPHA3 EPHA4	1.99e-06	21	41	3	10495276
Pubmed	Roles of Eph receptors and ephrins in segmental patterning.	EPHB4 EPHA3 EPHA4	1.99e-06	21	41	3	11128993
Pubmed	Eph receptors and ephrins: regulators of guidance and assembly.	EPHB4 EPHA3 EPHA4	1.99e-06	21	41	3	10730216
Pubmed	Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling.	EPHB4 EPHA3 EPHA4	2.65e-06	23	41	3	19542359
Pubmed	The protein tyrosine kinase family of the human genome.	EPHB4 JAK1 EPHA3 EPHA4	2.85e-06	83	41	4	11114734
Pubmed	Eph receptors and their ephrin ligands are expressed in developing mouse pancreas.	EPHB4 EPHA3 EPHA4	3.03e-06	24	41	3	16446123
Pubmed	The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse.	UNC13B UNC13C	4.06e-06	3	41	2	23658173
Pubmed	Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition.	EPHA3 EPHA4	4.06e-06	3	41	2	36656913
Pubmed	Heterogeneous Presynaptic Distribution of Munc13 Isoforms at Retinal Synapses and Identification of an Unconventional Bipolar Cell Type with Dual Expression of Munc13 Isoforms: A Study Using Munc13-EXFP Knock-in Mice.	UNC13B UNC13C	4.06e-06	3	41	2	33105896
Pubmed	Identification and cloning of ELF-1, a developmentally expressed ligand for the Mek4 and Sek receptor tyrosine kinases.	EPHA3 EPHA4	4.06e-06	3	41	2	7522971
Pubmed	Nonconserved Ca(2+)/calmodulin binding sites in Munc13s differentially control synaptic short-term plasticity.	UNC13B UNC13C	4.06e-06	3	41	2	22966208
Pubmed	Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse.	UNC13B UNC13C	4.06e-06	3	41	2	15988013
Pubmed	Enhanced macroscopic desensitization shapes the response of alpha4 subtype-containing GABAA receptors to synaptic and extrasynaptic GABA.	GABRG2 GABRA4	4.06e-06	3	41	2	17124266
Pubmed	EphA3 null mutants do not demonstrate motor axon guidance defects.	EPHA3 EPHA4	8.12e-06	4	41	2	14585969
Pubmed	Ephrins guide migrating cortical interneurons in the basal telencephalon.	EPHA3 EPHA4	8.12e-06	4	41	2	20473036
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	EPHB4 JAK1 GRAMD1B PPP2R2A POLR1A PRKAG2 PPP2R2D EPHA4	9.47e-06	910	41	8	36736316
Pubmed	An active vesicle priming machinery suppresses axon regeneration upon adult CNS injury.	UNC13B UNC13C	1.35e-05	5	41	2	34706221
Pubmed	Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.	EPHB4 EPHA4	1.35e-05	5	41	2	21935409
Pubmed	Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases.	EPHA3 EPHA4	1.35e-05	5	41	2	8552593
Pubmed	Identification of a Munc13-sensitive step in chromaffin cell large dense-core vesicle exocytosis.	UNC13B UNC13C	1.35e-05	5	41	2	26575293
Pubmed	Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.	EPHB4 EPHA3 EPHA4	1.69e-05	42	41	3	11439183
Pubmed	Polysialylated NCAM and ephrinA/EphA regulate synaptic development of GABAergic interneurons in prefrontal cortex.	EPHA3 EPHA4	2.03e-05	6	41	2	22275477
Pubmed	Protein phosphatase 2A (PP2A) holoenzymes regulate death-associated protein kinase (DAPK) in ceramide-induced anoikis.	PPP2R2A PPP2R2D	2.03e-05	6	41	2	20220139
Pubmed	Opposing gradients of ephrin-As and EphA7 in the superior colliculus are essential for topographic mapping in the mammalian visual system.	EPHA3 EPHA4	2.03e-05	6	41	2	15996548
Pubmed	Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes.	EPHA3 EPHA4	2.03e-05	6	41	2	12895420
Pubmed	SOCS-1 localizes to the microtubule organizing complex-associated 20S proteasome.	JAK1 CUL2	2.84e-05	7	41	2	15456882
Pubmed	Complex formation between EphB2 and Src requires phosphorylation of tyrosine 611 in the EphB2 juxtamembrane region.	EPHA3 EPHA4	2.84e-05	7	41	2	9632142
Pubmed	HSF1 transcriptional activity is modulated by IER5 and PP2A/B55.	PPP2R2A PPP2R2D	2.84e-05	7	41	2	25816751
Pubmed	Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction.	JAK1 EPHA4	2.84e-05	7	41	2	2466296
Pubmed	Developmental changes in the expression of gamma-aminobutyric acidA/benzodiazepine receptor subunit mRNAs in the murine inferior olivary complex.	GABRG2 GABRA4	2.84e-05	7	41	2	7560270
Pubmed	Pou3f4-mediated regulation of ephrin-b2 controls temporal bone development in the mouse.	EPHB4 EPHA4	2.84e-05	7	41	2	25299585
Pubmed	Munc13 supports fusogenicity of non-docked vesicles at synapses with disrupted active zones.	UNC13B UNC13C	2.84e-05	7	41	2	36398873
Pubmed	Mistargeting hippocampal axons by expression of a truncated Eph receptor.	EPHA3 EPHA4	3.78e-05	8	41	2	12124402
Pubmed	EphA receptors direct the differentiation of mammalian neural precursor cells through a mitogen-activated protein kinase-dependent pathway.	EPHA3 EPHA4	3.78e-05	8	41	2	15145949
Pubmed	Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells.	UNC13B UNC13C	3.78e-05	8	41	2	25609709
Pubmed	EphrinB1 modulates glutamatergic inputs into POMC-expressing progenitors and controls glucose homeostasis.	EPHB4 EPHA4	4.86e-05	9	41	2	33253166
Pubmed	Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development.	PPP2R2A PPP2R2D	4.86e-05	9	41	2	19762425
Pubmed	Topographic guidance labels in a sensory projection to the forebrain.	EPHA3 EPHA4	4.86e-05	9	41	2	9883724
Pubmed	EphrinA5 Signaling Is Required for the Distinctive Targeting of Raphe Serotonin Neurons in the Forebrain.	EPHA3 EPHA4	6.07e-05	10	41	2	28197551
Pubmed	EphB2 guides axons at the midline and is necessary for normal vestibular function.	EPHB4 EPHA4	6.07e-05	10	41	2	10839360
Pubmed	Functional modifications of acid-sensing ion channels by ligand-gated chloride channels.	GABRG2 GABRA4	6.07e-05	10	41	2	21789198
Pubmed	Quantitative assessment of computational models for retinotopic map formation.	EPHA3 EPHA4	6.07e-05	10	41	2	25367067
Pubmed	Expression of ephrin-A ligands and EphA receptors in the developing mouse tooth and its supporting tissues.	EPHA3 EPHA4	7.41e-05	11	41	2	15517401
Pubmed	Bidirectional ephrinB3/EphA4 signaling mediates the segregation of medial ganglionic eminence- and preoptic area-derived interneurons in the deep and superficial migratory stream.	EPHA3 EPHA4	7.41e-05	11	41	2	22171039
Pubmed	Anatomical coupling of sensory and motor nerve trajectory via axon tracking.	EPHA3 EPHA4	7.41e-05	11	41	2	21791286
Pubmed	Molecular and functional architecture of striatal dopamine release sites.	UNC13B UNC13C	7.41e-05	11	41	2	34767769
Pubmed	Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex.	GABRG2 GABRA4	7.41e-05	11	41	2	38894703
Pubmed	Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5.	EPHA3 EPHA4	7.41e-05	11	41	2	10559410
Pubmed	An Eph-related receptor protein tyrosine kinase gene segmentally expressed in the developing mouse hindbrain.	EPHA3 EPHA4	8.88e-05	12	41	2	1281307
Pubmed	Ephrin/ephrin receptor expression during early stages of mouse inner ear development.	EPHA3 EPHA4	8.88e-05	12	41	2	21465626
Pubmed	EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion.	EPHA3 EPHA4	8.88e-05	12	41	2	19247962
Pubmed	Eph-ephrin A system regulates murine blastocyst attachment and spreading.	EPHA3 EPHA4	1.05e-04	13	41	2	17039519
Pubmed	EphA family gene expression in the developing mouse neocortex: regional patterns reveal intrinsic programs and extrinsic influence.	EPHA3 EPHA4	1.05e-04	13	41	2	12528186
Pubmed	Tlx1/3 and Ptf1a control the expression of distinct sets of transmitter and peptide receptor genes in the developing dorsal spinal cord.	GABRG2 GRIN2D GABRA4	1.22e-04	81	41	3	22723691
Pubmed	The biochemical anatomy of cortical inhibitory synapses.	GABRG2 GABRA4	1.22e-04	14	41	2	22768092
Pubmed	A role for the EphA family in the topographic targeting of vomeronasal axons.	EPHA3 EPHA4	1.22e-04	14	41	2	11222144
Pubmed	In the developing cerebral cortex: axonogenesis, synapse formation, and synaptic plasticity are regulated by SATB2 target genes.	EPHA3 EPHA4	1.41e-04	15	41	2	36028553
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	EPHA10 EPHA3 EPHA4	1.72e-04	91	41	3	28558017
Pubmed	Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities.	EPHA3 EPHA4	1.82e-04	17	41	2	19168674
Pubmed	Complex patterns of cell growth in the placenta in normal pregnancy and as adaptations to maternal diet restriction.	CTSL GYS1	2.05e-04	18	41	2	31917811
Pubmed	Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity.	EPHB4 EPHA4	2.05e-04	18	41	2	18651661
Pubmed	GABA neurotransmitter signaling in the developing mouse lens: dynamic regulation of components and functionality.	GABRG2 GABRA4	2.05e-04	18	41	2	18985723
Pubmed	Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.	GABRG2 GABRA4	2.05e-04	18	41	2	19078961
Pubmed	Ppp2r2a Knockout Mice Reveal That Protein Phosphatase 2A Regulatory Subunit, PP2A-B55α, Is an Essential Regulator of Neuronal and Epidermal Embryonic Development.	PPP2R2A PPP2R2D	2.29e-04	19	41	2	32582689
Pubmed	Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting.	EPHB4 EPHA4	2.29e-04	19	41	2	35294885
Pubmed	PTPN14 is required for the density-dependent control of YAP1.	CUL2 PPP2R2A	2.81e-04	21	41	2	22948661
Pubmed	Ephrin-B2 governs morphogenesis of endolymphatic sac and duct epithelia in the mouse inner ear.	EPHB4 EPHA4	2.81e-04	21	41	2	24583262
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TMEM63B ATP6V1A PPP2R2A MBTPS1 ANKMY1 POLR1A PRKAG2 NAIP	2.99e-04	1489	41	8	28611215
Pubmed	Genome-wide, large-scale production of mutant mice by ENU mutagenesis.	JAK1 OTOG	3.09e-04	22	41	2	10932192
Pubmed	Transient expression of ephrin b2 in perinatal skin is required for maintenance of keratinocyte homeostasis.	EPHB4 EPHA4	3.38e-04	23	41	2	19571816
Pubmed	Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions.	EPHA3 EPHA4	3.38e-04	23	41	2	25480914
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PPP2R2A SETX INO80 PPP2R2D PLCH2	3.81e-04	529	41	5	14621295
Pubmed	Increased dosage of the imprinted Ascl2 gene restrains two key endocrine lineages of the mouse Placenta.	CTSL GYS1	4.33e-04	26	41	2	27542691
Pubmed	Redundant functions of RIM1alpha and RIM2alpha in Ca(2+)-triggered neurotransmitter release.	UNC13B UNC13C	4.33e-04	26	41	2	17124501
Pubmed	Functional analysis of secreted and transmembrane proteins critical to mouse development.	MBTPS1 EPHA4	6.17e-04	31	41	2	11431694
Pubmed	The synaptic vesicle cycle.	UNC13B UNC13C	6.17e-04	31	41	2	15217342
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	JAK1 CUL2 PIP5K1B PPP2R2A GET4 HAS1 GYS1	6.88e-04	1284	41	7	17353931
Pubmed	Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation.	EPHA3 EPHA4	7.00e-04	33	41	2	26830346
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	EPHB4 JAK1 CUL2 ATP6V1A SETX CTSL GYS1	7.30e-04	1297	41	7	33545068
Interaction	CTSL3P interactions	CTSL CTSL3P	3.65e-06	2	39	2	int:CTSL3P
Interaction	HSPA1B interactions	EPHB4 CUL2 INO80 EPHA10 EPHA3 EPHA4	2.28e-05	301	39	6	int:HSPA1B
Cytoband	9q21.33	CTSL CTSL3P	1.18e-04	18	41	2	9q21.33
Cytoband	Ensembl 112 genes in cytogenetic band chr9q21	PIP5K1B CTSL CTSL3P	7.57e-04	199	41	3	chr9q21
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB4 EPHA10 EPHA3 EPHA4	9.09e-09	14	33	4	1095
GeneFamily	Sterile alpha motif domain containing	EPHB4 EPHA10 EPHA3 EPHA4	1.92e-05	88	33	4	760
GeneFamily	UNC13 homologs	UNC13B UNC13C	1.93e-05	4	33	2	836
GeneFamily	Fibronectin type III domain containing	EPHB4 EPHA10 EPHA3 EPHA4	1.98e-04	160	33	4	555
GeneFamily	WD repeat domain containing\|Protein phosphatase 2 regulatory subunits	PPP2R2A PPP2R2D	3.34e-04	15	33	2	696
GeneFamily	Gamma-aminobutyric acid type A receptor subunits	GABRG2 GABRA4	5.42e-04	19	33	2	563
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_4\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	EPHB4 FUT6 CTSL KCNH4	8.80e-06	142	41	4	5ef69032ed7dc5f2244b84e8c6662290bf59a34b
ToppCell	IIF-Lymphocyte-T_NK-NK_CD56bright\|IIF / Disease, Lineage and Cell Type	JAK1 GFOD1 ENPP3 PLCH2	1.44e-05	161	41	4	b1bd1074ecba4cf171d748e2f686e9a99c0f0e89
ToppCell	COVID-19_Moderate-NK_CD56bright\|World / disease group, cell group and cell class	JAK1 ENPP3 PLCH2 EPHA4	1.79e-05	170	41	4	caa6a534c1e9639caced9a51680f5c905f061bcc
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|metastatic_Lymph_Node / Location, Cell class and cell subclass	UNC13B GRIN2D GLB1L GYS1	1.87e-05	172	41	4	f673a2e697b46e7cfa4186cb3fb2b98e3c83703e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JAK1 GFOD1 PLCH2 EPHA4	2.00e-05	175	41	4	e219b61d6bc078d44ea7d06191d3462654d857a1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JAK1 GFOD1 PLCH2 EPHA4	2.00e-05	175	41	4	bd16c80418bf71127e6f1e50edf83967c9218b42
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	JAK1 GFOD1 PLCH2 EPHA4	2.00e-05	175	41	4	0ed053aa8353c72ff37fee830672704a3ddc7d85
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	JAK1 GFOD1 PLCH2 EPHA4	2.00e-05	175	41	4	0124a3c4696b39cee8b566e94603d1d3d128bfa5
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 UNC13C HAS1 PLCH2	2.24e-05	180	41	4	f6a2208960d0df1500c974cc44c3c054cd7475a9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C MYO16 EPHA10 OTOG	2.44e-05	184	41	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C MYO16 EPHA10 OTOG	2.44e-05	184	41	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C MYO16 EPHA10 OTOG	2.44e-05	184	41	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_CD56bright\|COVID-19_Mild / Disease group, lineage and cell class	JAK1 GFOD1 PLCH2 EPHA4	2.44e-05	184	41	4	f67308228bb6a5d624279fbb04db25a2f4087c9b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	JAK1 GFOD1 PLCH2 EPHA4	2.49e-05	185	41	4	3a046c948524e5d0e986cd645e318d6930d7e0ee
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	JAK1 GFOD1 PLCH2 EPHA4	2.49e-05	185	41	4	71d1a771026d9fa3528d46ac3d11353e396f2d87
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JAK1 GFOD1 PLCH2 EPHA4	2.49e-05	185	41	4	df5d2309d19ac8d5e429afa785d0a480e75a8f9e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JAK1 GFOD1 PLCH2 EPHA4	2.49e-05	185	41	4	37b48218dd523049b57b13eb9cdb34e106cf91ea
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-H PIP5K1B GRIN2D MYO16	2.65e-05	188	41	4	0501a8aa850bd2e347020abd1cac4d8075738189
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B UNC13C MYO16 EPHA3	2.65e-05	188	41	4	4544552ebd67e9eb3e40d8511bb2b03a6e1178f8
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B UNC13C MYO16 EPHA3	2.71e-05	189	41	4	222e67d3fd106c43b0cae6538dddeaa7be1f759f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B UNC13C MYO16 EPHA3	2.88e-05	192	41	4	bd3fa6c8fcb618db64d11f25cabaf08608957c35
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B UNC13C MYO16 EPHA3	2.88e-05	192	41	4	63d1b3efe93e5ff939278ebe40bacb38218ea09b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B UNC13C MYO16 EPHA3	2.88e-05	192	41	4	342842378c20267c5044bdd622515e8b9f895623
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like-IPCs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	GRAMD1B GFOD1 PLCH2 EPHA3	3.00e-05	194	41	4	2378a98452f6ec33870eeb994b8b812e9b507f4c
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	GRAMD1B GFOD1 PLCH2 EPHA3	3.00e-05	194	41	4	7ba0445a486feac18b3a4fd6f2855c102e374e2d
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	GRAMD1B PRKAG2 CTSL NAIP	3.06e-05	195	41	4	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-41\|World / Primary Cells by Cluster	GABRG2 ST8SIA3 MYO16 EPHA4	3.12e-05	196	41	4	dee0984cd63a1a2fdebb4421af48ab566a5b684e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37\|World / Primary Cells by Cluster	GABRG2 ATP6V1A ST8SIA3 EPHA4	3.18e-05	197	41	4	00d756bc0231e1b3b88430214338c1059cb11106
ToppCell	MS-IIF-Lymphocyte-T/NK-NK_CD56bright\|IIF / Disease, condition lineage and cell class	JAK1 GFOD1 ENPP3 PLCH2	3.31e-05	199	41	4	9eb2b7d4900b118338590db778a47504559e228d
ToppCell	mild-NK_CD56bright\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JAK1 GFOD1 PLCH2 EPHA4	3.37e-05	200	41	4	a195bc6784346f706d4cd5b740adac1d950ce88a
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_CD56bright\|COVID-19_Mild / Disease, condition lineage and cell class	JAK1 GFOD1 PLCH2 EPHA4	3.37e-05	200	41	4	bb21e26a8b7cbceddb1ab5163a223a186d914da4
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_CD56bright\|COVID-19_Severe / Disease, condition lineage and cell class	JAK1 GFOD1 PLCH2 EPHA4	3.37e-05	200	41	4	12626d046a3ed8db1c9bd603ada5b97ead93e587
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor-4\|TCGA-Testes / Sample_Type by Project: Shred V9	FUT6 ENPP3 PLCH2	1.49e-04	112	41	3	3ec029eac64247c5e48074dad5c71df690e84f4c
ToppCell	Control-B_naive-9\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	GRAMD1B GET4 GYS1	1.97e-04	123	41	3	36d509eae874733f1a4f8189ad3000136ff6425e
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Krt73\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PIP5K1B ENPP3 EPHA3	2.37e-04	131	41	3	9ca209a8652aae603c4a867ea06b06ac51e7d189
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|Lung / Manually curated celltypes from each tissue	GRAMD1B POLR1A PLCH2	3.01e-04	142	41	3	c3db15bcb305ebdf5c9ca0b5c8ce63fab978590b
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1\|Striatum / BrainAtlas - Mouse McCarroll V32	HAS1 ST8SIA3 KCNH4	3.26e-04	146	41	3	7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09
ToppCell	facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 ST8SIA3 CTSL	3.33e-04	147	41	3	9d7e965fe61bd7b31e09c4b2129a5a98c36f4811
ToppCell	facs-Marrow-B-cells-24m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GABRG2 ST8SIA3 CTSL	3.33e-04	147	41	3	38552953ff65a0fc20bee6ef57dc5885306ad18b
ToppCell	LPS-antiTNF-Hematopoietic_Mast-Mast_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD1B ENPP3 OTOG	3.46e-04	149	41	3	59aa1f2a5cbeba64c4529fb05f544db17fd8b188
ToppCell	LPS-antiTNF-Hematopoietic_Mast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRAMD1B ENPP3 OTOG	3.46e-04	149	41	3	1527cdd98a2734cbf8ce4c6170557280b71c55cb
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG2 UNC13C EPHA4	3.60e-04	151	41	3	16fc903fc71e25717b9908416f0bcd29c0a65a61
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_4\|368C / Donor, Lineage, Cell class and subclass (all cells)	FUT6 CTSL KCNH4	4.11e-04	158	41	3	f9cfb110342be3c91aba9914805332f22ba89101
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B PIP5K1B GET4	4.18e-04	159	41	3	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GRAMD1B NOX5 CTSL	4.66e-04	165	41	3	436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GRAMD1B NOX5 CTSL	4.66e-04	165	41	3	242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B PIP5K1B UNC13C	4.66e-04	165	41	3	dc570154baed59ed109e5369589448e075ba66a9
ToppCell	Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GRIN2D GFOD1 MYO16	4.83e-04	167	41	3	9efb9511a211d0824bb97f82c1a5860c43d2138f
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	POLR1A FUT6 PLCH2	4.83e-04	167	41	3	99db8871c62336bd215efb65e969783d2b6003b0
ToppCell	Cerebellum-Neuronal-Inhibitory\|Cerebellum / BrainAtlas - Mouse McCarroll V32	GRIN2D GFOD1 MYO16	4.83e-04	167	41	3	904c613aac3f9919a432b110bb1dcc832b5aec0a
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GFOD1 CTSL EPHA4	4.91e-04	168	41	3	e40a3f85be7e9bb23bfbc1f9cb5e5fc54bb43863
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GFOD1 CTSL EPHA4	4.91e-04	168	41	3	b1d6c35a5ae69c8638afd68c2be5bc9ce6fd2659
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac\|Myeloid_cells / Location, Cell class and cell subclass	UNC13B GRIN2D GYS1	5.00e-04	169	41	3	dba8f5599aa21feef5b7fdfed2e3ab54748d80f7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UNC13C PLCH2 EPHA4	5.08e-04	170	41	3	3174ea9cf93892a8b41de10fd4ff6f06bb41502d
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4-5_RORB_ASCL1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UNC13C MYO16 EPHA3	5.35e-04	173	41	3	2e35bf2b5534a289d93a09faae660f665c131062
ToppCell	COVID-19_Moderate-NK_CD56bright\|COVID-19_Moderate / disease group, cell group and cell class	JAK1 GFOD1 EPHA4	5.35e-04	173	41	3	a07dcb1e555caaa2235aec219334fcbf2d07f10c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C HAS1 PLCH2	5.53e-04	175	41	3	65571d775d26a40e979dbf290a8e4320c0d9fb3f
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG2 ST8SIA3 EPHA10	5.53e-04	175	41	3	19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	5.62e-04	176	41	3	1595dbeee336a81e581325d63208ec6262664ee9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	5.72e-04	177	41	3	2f81b26be89cc2fd8eafadaf7eae3c6ad6521462
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PIP5K1B ATP6V1A UNC13C	5.81e-04	178	41	3	51d2188406f04329311b2efd1108fc36617a860e
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1\|TCGA-Adrenal / Sample_Type by Project: Shred V9	GABRG2 ST8SIA3 GFOD1	5.91e-04	179	41	3	431e1b29015ec817f778499106d24b19cfc825ae
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GABRG2 ST8SIA3 EPHA10	5.91e-04	179	41	3	af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRIN2D MYO16 PLCH2	5.91e-04	179	41	3	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	5.91e-04	179	41	3	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells\|Fibroblasts / Location, Cell class and cell subclass	MBTPS1 HAS1 EPHA4	5.91e-04	179	41	3	83506e00fe99b6450efd2f13f716926a0a4b03cd
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 ENPP3	6.00e-04	180	41	3	f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	UNC13B ANKMY1 GFOD1	6.00e-04	180	41	3	c72f15763ba707189e29c85db533557f01c7fdb1
ToppCell	droplet-Liver-LIVER-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C HAS1 GABRA4	6.00e-04	180	41	3	47e345359064dc8ceec982b062e47802e728b43f
ToppCell	LV\|World / Chamber and Cluster_Paper	GRAMD1B PIP5K1B GABRA4	6.00e-04	180	41	3	5ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCell	droplet-Liver-LIVER-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C HAS1 GABRA4	6.00e-04	180	41	3	3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	6.20e-04	182	41	3	e1e58176f533092b6b974ca1ce8b02192a6e193d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UNC13C EPHA3 EPHA4	6.20e-04	182	41	3	14a117c5e50db31ee1b2cf4df4d133451fd6d55f
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GRIN2D ENPP3 MYO16	6.20e-04	182	41	3	4cd5eb13f78f4f377932c50ac2acb4ac0cd14c12
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	6.20e-04	182	41	3	4a9c13932e7163fd37a3dcc4c6ca3bbea5372459
ToppCell	wk_15-18-Epithelial-PNS-SST+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GABRG2 ST8SIA3 EPHA10	6.20e-04	182	41	3	a7e77aaaddabf78c7784f72b3431703fc5ee4a8c
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	6.20e-04	182	41	3	57bb5a2da976464ba7c4460106bd9f692008ebd9
ToppCell	Globus_pallidus-Neuronal-Inhibitory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	ATP6V1A GRIN2D EPHA10	6.20e-04	182	41	3	04ccfa951eaa31fed6d140edb6c702d49363c5fa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	6.30e-04	183	41	3	85446581999cd66b171c4f69b7eb8b0bbbaa8617
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related-ICC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GFOD1 CTSL EPHA4	6.30e-04	183	41	3	262387ee8d43b96e5f1a77c75124459a506a6172
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-stromal_related\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GFOD1 CTSL EPHA4	6.30e-04	183	41	3	c85a707acbcb582912e8ac080a36d05f91cfd7a2
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPHB4 GFOD1 EPHA4	6.30e-04	183	41	3	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG2 ST8SIA3 EPHA10	6.40e-04	184	41	3	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B GRIN2D MYO16	6.40e-04	184	41	3	e2de27cee3ea80f9b7a9a7884ceceeaa67b3214a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B GRIN2D MYO16	6.40e-04	184	41	3	2ba98708dfd7f1b2a661578a334684094ff453ad
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B PIP5K1B MYO16	6.40e-04	184	41	3	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	6.40e-04	184	41	3	9434731f651820b05335085582960f08fbf895de
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG2 ST8SIA3 EPHA10	6.40e-04	184	41	3	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GABRG2 ST8SIA3 OTOG	6.50e-04	185	41	3	3d6711030ca4328357b06d5497cf98cdefcd7f4f
ToppCell	COVID-CD4-CD8_1\|COVID / Condition, Cell_class and T cell subcluster	PIP5K1B GET4 GFOD1	6.50e-04	185	41	3	c634bb04a081ae3214b68f6e4a147db5b2b916ed
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-H JAK1 GFOD1	6.60e-04	186	41	3	e84a0ba599935ca5e7af48e0fb0500e7ed195d55
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	PIP5K1B GRIN2D MYO16	6.60e-04	186	41	3	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell\|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-H JAK1 GFOD1	6.60e-04	186	41	3	1590fe72badffc79f1d390deb3207116ac2281bb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 PLCH2	6.60e-04	186	41	3	a417e1e21313a7e05951038cdef5ac672a9f727c
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	GABRG2 GRIN2D EPHA10	6.60e-04	186	41	3	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	UNC13C EPHA3 EPHA4	6.71e-04	187	41	3	f18628ffc7ff7c762b8339ba8822cf0c3157f469
ToppCell	COPD-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	PIP5K1B GYS1 EPHA4	6.71e-04	187	41	3	030af361f8bdcd0aff4ec1922702833325cf74d8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GRAMD1B FUT6 ENPP3	6.71e-04	187	41	3	f1356273bd3587b6883295edf15cb9cdb706c057
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	UNC13C PRKAG2 MYO16	6.71e-04	187	41	3	f6217d0dd425eac76900b44a4e48f45475f3ac36
ToppCell	10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	JAK1 GET4 HAS1	6.71e-04	187	41	3	f31d865ce2a21bdf64dbe29ee3e4505ab482604a
Drug	ethanol	JAK1 GABRG2 ATP6V1A MBTPS1 GRIN2D HAS1 PPP2R2D NOX5 GYS1 GABRA4	1.33e-06	837	40	10	CID000000702
Drug	DFC-28	EPHB4 EPHA3 EPHA4	1.80e-06	14	40	3	CID005743054
Drug	D2926_SIGMA	JAK1 MBTPS1 NOX5 KCNH4	4.81e-06	64	40	4	CID006400050
Drug	ponatinib	EPHB4 JAK1 EPHA3 EPHA4	6.13e-06	68	40	4	ctd:C545373
Drug	QX-314	GABRG2 GRIN2D EPHA3 GABRA4	1.29e-05	82	40	4	CID000003925
Drug	chlormethiazole	GABRG2 GRIN2D GABRA4	1.60e-05	28	40	3	CID000010783
Drug	NSC618487	JAK1 PIP5K1B MBTPS1 GRIN2D NOX5 CTSL GYS1 EPHA3 EPHA4	2.73e-05	933	40	9	CID000005279
Drug	Lorazepam	GABRG2 GABRA4	3.00e-05	5	40	2	ctd:D008140
Drug	secobarbital	GABRG2 GABRA4 NAIP	3.74e-05	37	40	3	CID000005193
Drug	Nivalenol hydrate	EPHB4 EPHA3 EPHA4	4.06e-05	38	40	3	CID000031829
Drug	zaleplon	GABRG2 GABRA4	4.49e-05	6	40	2	ctd:C085665
Drug	barbital	GABRG2 GABRA4 NAIP	5.50e-05	42	40	3	CID000002294
Drug	saclofen	GABRG2 GRIN2D GABRA4	6.33e-05	44	40	3	CID000122150
Drug	flurothyl	GABRG2 GRIN2D GABRA4	7.72e-05	47	40	3	CID000009528
Drug	Ro 15-4513	GABRG2 GABRA4	8.37e-05	8	40	2	ctd:C042957
Drug	Flumazenil	GABRG2 GABRA4	8.37e-05	8	40	2	ctd:D005442
Drug	sodium chloride	UNC13B ATP6V1A HAS1 POLR1A FUT6 NOX5 GLB1L GYS1	1.10e-04	865	40	8	CID000000206
Drug	CI-1033	EPHB4 EPHA3 EPHA4	1.11e-04	53	40	3	CID000156413
Drug	oxazepam	GABRG2 HAS1 GABRA4	1.11e-04	53	40	3	CID000004616
Drug	2-hydroxysaclofen	GABRG2 GRIN2D GABRA4	1.53e-04	59	40	3	CID000001564
Drug	AC1L1BIT	GABRG2 EPHA4 GABRA4	1.60e-04	60	40	3	CID000001457
Drug	fosazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000037114
Drug	C19H18ClN3O	GABRG2 GABRA4	1.64e-04	11	40	2	CID000027452
Drug	flutoprazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000003400
Drug	Arfendazam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000065803
Drug	camazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000037367
Drug	triflubazam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000031157
Drug	Bu-1014	GABRG2 GABRA4	1.64e-04	11	40	2	CID015942721
Drug	Zapizolam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000068832
Drug	Reclazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID003052777
Drug	iclazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000068777
Drug	menitrazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000189875
Drug	Serin hydrazid	GABRG2 GABRA4	1.64e-04	11	40	2	CID000041637
Drug	sulazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000017931
Drug	elfazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000065445
Drug	uldazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000034274
Drug	gidazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000121919
Drug	fletazepam	GABRG2 GABRA4	1.64e-04	11	40	2	CID000036834
Drug	CGP 35348	GABRG2 GRIN2D GABRA4	1.77e-04	62	40	3	CID000107699
Drug	iso-form	ATP6V1A PPP2R2A PPP2R2D	1.85e-04	63	40	3	CID000069676
Drug	AP-7	GABRG2 GRIN2D GABRA4	1.85e-04	63	40	3	CID000003122
Drug	AC1L1J7N	GABRG2 GRIN2D GABRA4	1.94e-04	64	40	3	CID000004902
Drug	beta-carboline	GABRG2 HAS1 GABRA4	1.94e-04	64	40	3	CID000064961
Drug	SB-205384	GABRG2 GABRA4	1.96e-04	12	40	2	CID000197690
Drug	U-93631	GABRG2 GABRA4	1.96e-04	12	40	2	CID000197626
Drug	haloxazolam	GABRG2 GABRA4	1.96e-04	12	40	2	CID000003563
Drug	pivoxazepam	GABRG2 GABRA4	1.96e-04	12	40	2	CID000068722
Drug	doxefazepam	GABRG2 GABRA4	1.96e-04	12	40	2	CID000038668
Drug	razobazam	GABRG2 GABRA4	1.96e-04	12	40	2	CID000071228
Drug	AC1MVFYM	GABRG2 GABRA4	2.32e-04	13	40	2	CID003707225
Drug	nerisopam	GABRG2 GABRA4	2.32e-04	13	40	2	CID000065875
Drug	Ro 11-3128	GABRG2 GABRA4	2.32e-04	13	40	2	CID000093364
Drug	cinolazepam	GABRG2 GABRA4	2.32e-04	13	40	2	CID003033621
Drug	flutazolam	GABRG2 GABRA4	2.32e-04	13	40	2	CID000003398
Drug	alpha IMGBL	GABRG2 GABRA4	2.32e-04	13	40	2	CID000131516
Drug	4-PIOL	GABRG2 GABRA4	2.32e-04	13	40	2	CID000125520
Drug	metaclazepam	GABRG2 GABRA4	2.32e-04	13	40	2	CID000071272
Drug	enflurane	GABRG2 GRIN2D GABRA4	2.33e-04	68	40	3	CID000003226
Drug	BAPTA	GABRG2 MBTPS1 GRIN2D NOX5 GABRA4	2.47e-04	324	40	5	CID000104751
Drug	phaclofen	GABRG2 GRIN2D GABRA4	2.53e-04	70	40	3	CID000001641
Drug	felbamate	GABRG2 GRIN2D GABRA4	2.53e-04	70	40	3	CID000003331
Drug	beta-CCt	GABRG2 GABRA4	2.70e-04	14	40	2	CID000124514
Drug	Me-lex	GABRG2 GABRA4	2.70e-04	14	40	2	CID000004177
Drug	ethyl loflazepate	GABRG2 GABRA4	2.70e-04	14	40	2	CID000003299
Drug	acamprosate	GABRG2 GRIN2D GABRA4	2.99e-04	74	40	3	CID000071158
Drug	SR 95103	GABRG2 GABRA4	3.11e-04	15	40	2	CID000125958
Drug	HA100	HAS1 NOX5	3.11e-04	15	40	2	CID000003545
Drug	cytidine diphosphate-glucose	ENPP3 GYS1	3.11e-04	15	40	2	CID000000292
Drug	loprazolam	GABRG2 GABRA4	3.11e-04	15	40	2	CID003033860
Drug	GV-C	JAK1 HAS1	3.11e-04	15	40	2	CID016040293
Drug	premazepam	GABRG2 GABRA4	3.11e-04	15	40	2	CID000072104
Drug	pinazepam	GABRG2 GABRA4	3.11e-04	15	40	2	CID000040391
Drug	fludiazepam	GABRG2 GABRA4	3.11e-04	15	40	2	CID000003369
Drug	TBOB	GABRG2 GABRA4	3.11e-04	15	40	2	CID000114986
Drug	girisopam	GABRG2 GABRA4	3.11e-04	15	40	2	CID000071257
Drug	BM 17.0744	GLB1L GYS1	3.56e-04	16	40	2	CID009929731
Drug	tetrazepam	GABRG2 GABRA4	3.56e-04	16	40	2	CID000025215
Drug	Ro 19-4603	GABRG2 GABRA4	3.56e-04	16	40	2	CID000127382
Drug	P858	GABRG2 GABRA4	3.56e-04	16	40	2	CID000004617
Drug	nimetazepam	GABRG2 GABRA4	3.56e-04	16	40	2	CID000004496
Drug	LY294002; Down 200; 10uM; PC3; HT_HG-U133A	ATP6V1A MBTPS1 FUT6 GFOD1	3.82e-04	196	40	4	5942_DN
Drug	Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A	UNC13B PIP5K1B SETX GABRA4	3.89e-04	197	40	4	3019_DN
Drug	(cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A	ANKMY1 HAS1 FUT6 ST8SIA3	3.97e-04	198	40	4	4363_UP
Drug	zolpidem	GABRG2 GABRA4	4.03e-04	17	40	2	ctd:C049109
Drug	dihydroxyaflavinine	GABRG2 GABRA4	4.03e-04	17	40	2	CID000156857
Drug	CL 218,872	GABRG2 GABRA4	4.03e-04	17	40	2	CID000107950
Drug	DNQX	GABRG2 GRIN2D GABRA4	4.19e-04	83	40	3	CID003899541
Drug	AC1L1B1W	GABRG2 GRIN2D GABRA4	4.34e-04	84	40	3	CID000001248
Drug	D-N-Q	GABRG2 GRIN2D GABRA4	4.34e-04	84	40	3	CID000003140
Drug	D90A	SETX NOX5 NAIP	4.49e-04	85	40	3	CID000023715
Drug	abecarnil	GABRG2 GABRA4	4.52e-04	18	40	2	CID000065914
Drug	cloxazolam	GABRG2 GABRA4	4.52e-04	18	40	2	CID000002816
Drug	clorazepate	GABRG2 GABRA4	4.52e-04	18	40	2	CID000002809
Drug	lormetazepam	GABRG2 GABRA4	4.52e-04	18	40	2	CID000013314
Drug	phenazepam	GABRG2 GABRA4	4.52e-04	18	40	2	CID000040113
Drug	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	UNC13B JAK1 GRAMD1B UNC13C GFOD1 ENPP3 EPHA4	4.60e-04	807	40	7	ctd:C548651
Drug	IPSP	GABRG2 GRIN2D GABRA4	4.81e-04	87	40	3	CID000022083
Drug	ZK 93426	GABRG2 GABRA4	5.05e-04	19	40	2	CID000115210
Drug	etifoxine	GABRG2 GABRA4	5.05e-04	19	40	2	CID000030768
Drug	pregnanolone	GABRG2 GRIN2D GABRA4	5.31e-04	90	40	3	CID000031402
Disease	human papilloma virus infection, oropharynx cancer	UNC13C GFOD1 MYO16	5.56e-05	53	41	3	EFO_0001668, EFO_1001931
Disease	epilepsy (implicated_via_orthology)	UNC13B GABRG2 UNC13C GRIN2D	7.75e-05	163	41	4	DOID:1826 (implicated_via_orthology)
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	PPP2R2A PPP2R2D	1.23e-04	12	41	2	DOID:1441 (implicated_via_orthology)
Disease	response to angiotensin-converting enzyme inhibitor	GABRG2 PIP5K1B EPHA4	1.76e-04	78	41	3	EFO_0005325
Disease	creatinine measurement, glomerular filtration rate	PIP5K1B INO80 PRKAG2	5.80e-04	117	41	3	EFO_0004518, EFO_0005208
Disease	response to angiotensin receptor blocker	POLR1A PRKAG2	7.99e-04	30	41	2	EFO_0010735
Disease	Gastric Adenocarcinoma	EPHB4 EPHA10	1.80e-03	45	41	2	C0278701
Disease	brain connectivity measurement	JAK1 PRKAG2 MYO16 EPHA3	2.27e-03	400	41	4	EFO_0005210
Disease	memory performance	UNC13B UNC13C PRKAG2 EPHA4	2.46e-03	409	41	4	EFO_0004874
Disease	alcohol use disorder (implicated_via_orthology)	UNC13B UNC13C CTSL	2.52e-03	195	41	3	DOID:1574 (implicated_via_orthology)
Disease	Metastatic melanoma	EPHB4 EPHA4	2.58e-03	54	41	2	C0278883
Disease	Amyotrophic Lateral Sclerosis	SETX EPHA4	2.96e-03	58	41	2	C0002736
Disease	facial morphology measurement	INO80 POLR1A MYO16 EPHA3	3.92e-03	466	41	4	EFO_0007841
Disease	radiation-induced disorder	PPP2R2A MYO16	3.93e-03	67	41	2	EFO_0009565

Protein segments in the cluster

Peptide	Gene	Start	Entry
SHNMTRLRKFMVYFG	NAIP	616	Q13075
SESGVYMRFMRSHKC	PRKAG2	256	Q9UGJ0
YMRFMRSHKCYDIVP	PRKAG2	261	Q9UGJ0
VKFSHSGRYMMTRDY	PPP2R2A	291	P63151
YREGKHSFTMAMNAF	CTSL3P	11	Q5NE16
HSGRYMMTRDYLSVK	PPP2R2D	301	Q66LE6
HFFTSFGARDRTYMM	GRAMD1B	181	Q3KR37
MSLRLHYRMRFYFTN	JAK1	101	P23458
YMVYRKHTYMRLDGS	INO80	1136	Q9ULG1
SHSMRYFYTTMSRPG	HLA-H	26	P01893
YGRFLELHMYMTSAL	NOX5	666	Q96PH1
FRDMYQHLRSMGYFV	MBTPS1	661	Q14703
SGMRYLAEMSYVHRD	EPHB4	726	P54760
AFTIMHYAGRVMYDV	MYO16	901	Q9Y6X6
GSGMKYLSDMSYVHR	EPHA4	731	P54764
MRMHFTYDLKGSTYK	PIP5K1B	196	O14986
MYSRRSLYHSRMKDL	KCNH4	481	Q9UQ05
MTVYFHLRRKMGYFM	GABRA4	246	P48169
SAMKYLSEMGYVHRG	EPHA10	756	Q5JZY3
YHREYVSGFGKAMRM	ENPP3	626	O14638
YSMRRHTSKMRYKED	TMEM63B	221	Q5T3F8
HGFMLYRTYMTHTIF	GLB1L	411	Q6UWU2
VMSVYFDLSRRMGYF	GABRG2	261	P18507
GYEFTSKLHRMYTDM	CUL2	466	Q13617
HREGYGTMYMKTRLF	ANKMY1	56	Q9P2S6
KAMDGYFNLTMSYRS	FUT6	146	P51993
ASGMKYLSDMGYVHR	EPHA3	731	P29320
HLTNRMLSMGYATKY	HAS1	341	Q92839
MLSMGYATKYTSRSR	HAS1	346	Q92839
LGRYYMSARHMALSK	GYS1	601	P13807
SRYGFRIEDTGHMYM	OTOG	2201	Q6ZRI0
MTTRGCFFTREHYME	POLR1A	641	O95602
EAHQMYRTLFFRYMS	GET4	41	Q7L5D6
AFRMTSAAHYYPKLM	GFOD1	101	Q9NXC2
YHSGYVHKFRRTSVM	SETX	1836	Q7Z333
RMYMFHAGFRSQFAL	ST8SIA3	51	O43173
YREGKHSFTMAMNAF	CTSL	66	P07711
MRYGIESIYQAMTHF	UNC13C	1411	Q8NB66
FCAFYKMMSTRRDLY	PLCH2	231	O75038
YFRDMGYHVSMMADS	ATP6V1A	336	P38606
MRYGIESIYQAMTHF	UNC13B	791	O14795
GKFMSIYDVSTYMRT	SLC9C2	551	Q5TAH2
HRMDFLLAFSRGMYS	GRIN2D	881	O15399